ARTICLE AD BOX
Researchers at Oregon Health & Science University have developed a new molecule that may open the door to treating difficult cases of triple-negative breast cancer, a particularly aggressive form of the disease that currently has few effective treatment options.
In a study published in the journal Cell Reports Medicine, the team describes how the experimental molecule, called SU212, blocks an enzyme that plays a key role in cancer progression. The...

4 days ago
11







English (US) ·